ADHD Study for Adolescents

Adhansia XR vs Concerta

$50 per completed visit

 

Study Specific Details:

  • Adhansia vs Concerta- this is a phase 4, propective, open-label, randomized, pragmatic, study to investigate the treatment effectiveness. Dr. Handal can find out what medication/dose the participant is taking in case of emergency.
  • There will be a total of 6 visits over 6 months.
  • Participant are reimbursed $50 for their time and travel at the end of each completed visit.
  • Inclusion
  • Exclusion
  • Male or Female ages 12-17 or 19 and older.
  • Subject meets DSM-5 criteria for ADHD.
  • Subject is able to swallow a capsule.
  • No blood draws required for the study. 
  • History of an allergic reaction to MPH, AMP or sympathomimetic amines or known to be non-responsive to MPH or AMP treatment.
  • MAOIs are exclusionary and will have a 14 day washout.
  • Suicidal Ideation
  • Patients with a known sensitivity to the food dye tartrazine (yellow no. 5).
Questions? Give Us A Call!

Contact Us

Want to learn more about Harmonex Neuroscience Research?